Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 23(23)2022 Dec 02.
Article in English | MEDLINE | ID: mdl-36499507

ABSTRACT

Nobiletin (NOB) has attracted much attention owing to its outstanding bioactivities. This study aimed to investigate its anti-arrhythmic effect through electrophysiological and molecular docking studies. We assessed the anti-arrhythmic effects of NOB using aconitine-induced ventricular arrhythmia in a rat model and the electrophysiological effects of NOB on rat cardiomyocytes utilizing whole-cell patch-clamp techniques. Moreover, we investigated the binding characters of NOB with rNav1.5, rNav1.5/QQQ, and hNaV1.5 via docking analysis, comparing them with amiodarone and aconitine. NOB pretreatment delayed susceptibility to ventricular premature and ventricular tachycardia and decreased the incidence of fatal ventricular fibrillation. Whole-cell patch-clamp assays demonstrated that the peak current density of the voltage-gated Na+ channel current was reversibly reduced by NOB in a concentration-dependent manner. The steady-state activation and recovery curves were shifted in the positive direction along the voltage axis, and the steady-state inactivation curve was shifted in the negative direction along the voltage axis, as shown by gating kinetics. The molecular docking study showed NOB formed a π-π stacking interaction with rNav1.5 and rNav1.5/QQQ upon Phe-1762, which is the homolog to Phe-1760 in hNaV1.5 and plays an important role in antiarrhythmic action This study reveals that NOB may act as a class I sodium channel anti-arrhythmia agent.


Subject(s)
Anti-Arrhythmia Agents , Myocytes, Cardiac , Animals , Rats , Aconitine/metabolism , Anti-Arrhythmia Agents/pharmacology , Arrhythmias, Cardiac/metabolism , Molecular Docking Simulation , Myocytes, Cardiac/metabolism , Patch-Clamp Techniques , Sodium/metabolism , Sodium Channels/metabolism
2.
Heliyon ; 8(12): e12180, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36578418

ABSTRACT

Polyethylene mulching film plays a critical role in agricultural production. To clarify the impact of residual film and microplastics on soil microorganisms, this study examined four cotton fields with different film coverage years in typical areas of Xinjiang and analyzed the changes in soil bacterial and fungal community structure and diversity under residual film and microplastics using high-throughput sequencing technology. The results showed that the residual film in the 0-150 mm soil layers and 150-300 mm soil layers at the same sampling point had spatial distribution characteristics of 60-70% and 30-40%, respectively. The short period of the 0-10 years film mulching treatment increased the soil microbial diversity of the cotton field, whereas continuous film mulching for 25 years significantly decreased the soil microbial diversity, in which Proteobacteria was the dominant bacterial phylum and Ascomycetes was the dominant fungal phylum. The microbial diversity of the film-covered soil was lower than that of the control group. The spatial distribution of the residual film and microplastic changed the distribution of the microbial communities. The diversity of the microbial community structure of the 0-150 mm soil layers was higher than that of the 150-300 mm soil layers. The increase in residual film and microplastics had no significant effect on the diversity of the fungal community but decreased the diversity of the soil bacterial community and decreased the relative abundance of Proteobacteria and Campylobacter. In conclusion, long-term film mulching reduced the soil microbial diversity in cotton fields. This study provides a theoretical basis for understanding the impact of film residues on microorganisms and the ecological environment in typical areas.

4.
Eur J Pharmacol ; 904: 174158, 2021 Aug 05.
Article in English | MEDLINE | ID: mdl-33971179

ABSTRACT

Voltage-dependent K+ (Kv) channels play the role of returning the membrane potential to the resting state, thereby maintaining the vascular tone. Here, we used native smooth-muscle cells from rabbit coronary arteries to investigate the inhibitory effect of lorcainide, a class Ic antiarrhythmic agent, on Kv channels. Lorcainide inhibited Kv channels in a concentration-dependent manner with an IC50 of 4.46 ± 0.15 µM and a Hill coefficient of 0.95 ± 0.01. Although application of lorcainide did not change the activation curve, it shifted the inactivation curve toward a more negative potential, implying that lorcainide inhibits Kv channels by changing the channels' voltage sensors. The recovery time constant from channel inactivation increased in the presence of lorcainide. Furthermore, application of train steps (of 1 or 2 Hz) in the presence of lorcainide progressively augmented the inhibition of Kv currents, implying that lorcainide-induced inhibition of Kv channels is use (state)-dependent. Pretreatment with Kv1.5 or Kv2.1/2.2 inhibitors effectively reduced the amplitude of the Kv current but did not affect the inhibitory effect of lorcainide. Based on these results, we conclude that lorcainide inhibits vascular Kv channels in a concentration and use (state)-dependent manner by changing their inactivation gating properties. Considering the clinical efficacy of lorcainide, and the pathophysiological significance of vascular Kv channels, our findings should be considered when prescribing lorcainide to patients with arrhythmia and vascular disease.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Benzeneacetamides/pharmacology , Coronary Vessels/metabolism , Muscle, Smooth, Vascular/metabolism , Piperidines/pharmacology , Potassium Channels, Voltage-Gated/antagonists & inhibitors , Animals , Coronary Vessels/drug effects , Dose-Response Relationship, Drug , Kinetics , Kv1.5 Potassium Channel/antagonists & inhibitors , Kv1.5 Potassium Channel/metabolism , Male , Membrane Potentials/drug effects , Muscle, Smooth, Vascular/drug effects , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , Patch-Clamp Techniques , Potassium Channel Blockers/pharmacology , Potassium Channels, Voltage-Gated/metabolism , Rabbits , Shab Potassium Channels/antagonists & inhibitors , Shab Potassium Channels/metabolism
5.
Eur J Pharmacol ; 902: 174100, 2021 Jul 05.
Article in English | MEDLINE | ID: mdl-33878335

ABSTRACT

Tectochrysin, a flavonoid compound, can be isolated from propolis, Alpinia oxyphylla Miq, and Lychnophora markgravii. This study evaluated the efficacy of tectochrysin in the treatment of shrimp tropomyosin (ST)-induced mouse asthma. Mice were sensitized with intraperitoneal (i.p.) injection of ST together with aluminum hydroxide as an adjuvant to establish a mouse model of asthma. Mice were i.p.-treated daily with tectochrysin. IgE levels in plasma, Th2 cytokines from both bronchoalveolar lavage (BAL) fluid and splenocytes, and CD200R on basophils in peripheral blood were measured. Histological analyses of lung tissues and accumulation of leukocytes in BAL fluid were performed. Lung eosinophil peroxidase, catalase and glutathione peroxidase activities were examined. ST was found to markedly increase eosinophilic inflammation and Th2 response in mice. Tectochrysin treatment reduced the level of IgE in plasma, the percentage of eosinophils in total white blood cells in peripheral blood, the total number of cells in BAL fluid, and eosinophil peroxidase activity in lung tissues. Tectochrysin attenuated ST-induced infiltration of eosinophils and epithelial mucus secretion in lung tissues and suppressed the overproduction of Th2 cytokines (IL-4 and IL-5) in BAL fluid. Tectochrysin also attenuated Th2 cytokine (IL-4 and IL-5) production from antigen-stimulated murine splenocytes in vitro, decreased the expression of CD200R on basophils in peripheral blood of asthmatic mice and inhibited IL-4 secretion from IgE-sensitized RBL-2H3 cells. In addition, tectochrysin enhanced catalase and glutathione peroxidase activities in lung tissues. Our findings demonstrate that TEC ameliorates allergic airway inflammation by suppressing Th2 response and oxidative stress.


Subject(s)
Anti-Asthmatic Agents/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Asthma/drug therapy , Flavonoids/pharmacology , Hypersensitivity/drug therapy , Oxidative Stress/drug effects , Th2 Cells/immunology , Allergens/immunology , Animals , Anti-Asthmatic Agents/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Asthma/chemically induced , Asthma/immunology , Asthma/pathology , Basophils/metabolism , Catalase/metabolism , Disease Models, Animal , Eosinophils/metabolism , Female , Flavonoids/administration & dosage , Glutathione Peroxidase/metabolism , Hypersensitivity/immunology , Immunoglobulin E/blood , Injections, Intraperitoneal , Mice, Inbred C57BL , Mucus/drug effects , Shellfish Hypersensitivity/drug therapy , Shellfish Hypersensitivity/immunology , Tropomyosin/immunology
6.
Naunyn Schmiedebergs Arch Pharmacol ; 394(7): 1579-1588, 2021 07.
Article in English | MEDLINE | ID: mdl-33738513

ABSTRACT

Aloperine (ALO), a quinolizidine alkaloid extracted from Sophora alopecuroides L., modulates hypertension, ventricular remodeling, and myocardial ischemia. However, few studies have evaluated the effects of ALO on other cardiovascular parameters. Accordingly, in this study, we used a rat model of aconitine-induced ventricular arrhythmia to assess the effects of ALO. Notably, ALO pretreatment delayed the onset of ventricular premature and ventricular tachycardia and reduced the incidence of fatal ventricular fibrillation. Moreover, whole-cell patch-clamp assays in rats' ventricular myocyte showed that ALO (3, 10, and 30 µM) significantly reduced the peak sodium current density of voltage-gated Na+ channel currents (INa) in a concentration-dependent manner. The gating kinetics characteristics showed that the steady-state activation and recovery curve were shifted in positive direction along the voltage axis, respectively, and the steady-state inactivation curve was shifted in negative direction along the voltage axis, i.e., which was similar to the inhibitory effects of amiodarone. These results indicated that ALO had anti-arrhythmic effects, partly attributed to INa inhibition. ALO may act as a class I sodium channel anti-arrhythmia agent.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Myocytes, Cardiac/drug effects , Quinolizidines/pharmacology , Voltage-Gated Sodium Channel Blockers/pharmacology , Voltage-Gated Sodium Channels/physiology , Animals , Animals, Newborn , Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Arrhythmias, Cardiac/physiopathology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Female , Heart Ventricles/cytology , Heart Ventricles/drug effects , Male , Myocytes, Cardiac/physiology , Quinolizidines/therapeutic use , Rats , Rats, Sprague-Dawley , Voltage-Gated Sodium Channel Blockers/therapeutic use
7.
Article in English | MEDLINE | ID: mdl-35528830

ABSTRACT

Background: Huangkui capsule (HKC) comprises the total flavonoid extract of flowers of Abelmoschus manihot (L.) Medicus. This study aimed to explore the effects of HKC on lipopolysaccharide- (LPS-) induced acute lung injury (ALI) in mice and LPS-stimulated RAW 264.7 cells. Methods: Enzyme-linked immunosorbent assay, histopathology, spectrophotometry, and quantitative real-time polymerase chain reaction were used for the assessments. Statistical analysis was performed using a one-way analysis of variance. Results: LPS significantly increased lung inflammation, neutrophil infiltration, and oxidative stress and downregulated lung miR-451 expression. Treatment with HKC dramatically, reduced the total cell count in the bronchoalveolar lavage fluid (BALF), and inhibited myeloperoxidase activity in the lung tissues 24 h after LPS challenge. Histopathological analysis demonstrated that HKC attenuated LPS-induced tissue oedema and neutrophil infiltration in the lung tissues. Additionally, the concentrations of tumour necrosis factor- (TNF-) α and interleukin- (IL-) 6 in BALF and IL-6 in the plasma reduced after HKC administration. Moreover, HKC could enhance glutathione peroxidase and catalase activities and upregulate the expression of miR-451 in the lung tissues. In vitro experiments revealed that HKC inhibited the production of nitric oxide, TNF-α, and IL-6 in LPS-induced RAW 264.7 cells and mouse primary peritoneal macrophages. Additionally, HKC downregulated LPS-induced transcription of TNF-α and IL-6 in RAW 264.7 cells. Conclusions: These findings suggest that HKC has anti-inflammatory and antioxidative effects that may protect mice against LPS-induced ALI and macrophage activation.

8.
J Ethnopharmacol ; 281: 113548, 2021 Dec 05.
Article in English | MEDLINE | ID: mdl-33152427

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Huangkui capsule (HKC), extracted from Abelmoschus manihot (L.) medic (AM), as a patent proprietary Chinese medicine on the market for approximately 20 years, has been clinically used to treat chronic glomerulonephritis. Renal fibrosis has been implicated in the onset and development of diabetic nephropathy (DN). However, the potential application of HKC for preventing DN has not been evaluated. AIM OF THE STUDY: This study was designed to investigate the efficacy and underlying mechanisms of HKC combined with metformin (MET), the first-line medication for treating type 2 diabetes, in the treatment of renal interstitial fibrosis. MATERIALS AND METHODS: A rat model of diabetes-associated renal fibrosis was established by intraperitoneal injection of streptozotocin (STZ, 65 mg/kg) combined with a high-fat and high-glucose diet. The rats were randomly divided into five groups: normal control, DN, HKC (1.0 g/kg/day), MET (100 mg/kg/d), and HKC plus MET (1.0 g/kg/day + 100 mg/kg/d). Following drug administration for 8 weeks, we collected blood, urine, and kidney tissue for analysis. Biochemical markers and metabolic parameters were detected using commercial kits. Histopathological staining was performed to monitor morphological changes in the rat kidney. High-glucose-induced human kidney HK-2 cells were used to evaluate the renal protective effects of HKC combined with MET (100 µg/mL+10 mmol/L). MTT assay and acridine orange/ethidium bromide were used to examine cell proliferation inhibition rates and apoptosis. Immunofluorescence assay and Western blot analysis were performed to detect renal fibrosis-related proteins including Klotho, TGF-ß1, and phosphorylated (p)-p38. RESULTS: Combination therapy (HKC plus MET) significantly improved the weight, reduced blood glucose (BG), blood urea nitrogen (BUN), total cholesterol (T-CHO), triglycerides (TG), low-density lipoprotein (LDL) and increased the level of high-density lipoprotein (HDL) of DN rats. Combination therapy also significantly reduced urine serum creatinine (SCR) and urine protein (UP) levels as well as reduced the degrees of renal tubule damage and glomerulopathy in DN rats. Combination therapy ameliorated renal fibrosis, as evidenced by reduced levels of alpha-smooth muscle actin and fibronectin and increased expression of E-cadherin in the kidneys. Moreover, HKC plus MET alleviated the degree of DN in part via the Klotho/TGF-ß1/p38MAPK signaling pathway. In vitro experiments showed that combination therapy significantly inhibited cell proliferation and apoptosis and regulated fibrosis-related proteins in high-glucose (HG)-induced HK-2 cells. Further studies revealed that combination therapy suppressed cell proliferation and fibrosis by inhibiting the Klotho-dependent TGF-ß1/p38MAPK pathway. CONCLUSIONS: HKC plus MET in combination suppressed abnormal renal cell proliferation and fibrosis by inhibiting the Klotho-dependent TGF-ß1/p38MAPK pathway. Collectively, HKC combined with MET effectively improved DN by inhibiting renal fibrosis-associated proteins and blocking the Klotho/TGF-ß1/p38MAPK signaling pathway. These findings improve the understanding of the pathogenesis of diabetes-associated complications and support that HKC plus MET combination therapy is a promising strategy for preventing DN.


Subject(s)
Diabetic Nephropathies/chemically induced , Diabetic Nephropathies/drug therapy , Drugs, Chinese Herbal/pharmacology , Klotho Proteins/metabolism , Metformin/pharmacology , Transforming Growth Factor beta1/metabolism , Animals , Cell Line , Cell Proliferation/drug effects , Diabetes Mellitus, Experimental , Diet, High-Fat/adverse effects , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/administration & dosage , Gene Expression Regulation/drug effects , Glucose/administration & dosage , Glucose/adverse effects , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/pharmacology , Klotho Proteins/genetics , Male , Metformin/administration & dosage , Phytotherapy , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta1/genetics , p38 Mitogen-Activated Protein Kinases/genetics , p38 Mitogen-Activated Protein Kinases/metabolism
9.
Toxicol Lett ; 325: 1-13, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-32088201

ABSTRACT

Olfaction is often affected in parkinsonian patients and its disturbances precede the classical cognitive and locomotor dysfunction. The olfactory bulb might be the region of onset in Parkinson's disease (PD) pathogenesis, evidenced by the presence of disease-related protein aggregates and disturbed olfactory information processing. However, the underlying molecular mechanism that governs the olfactory bulb impairments remains unclear. This study was designed to investigate the relationship between olfactory bulb and inflammatory pathological alterations and the potential mechanisms. Here we found that rotenone led to typical parkinsonian symptoms and decreased tyrosine hydroxylase (TH)-positive neurons in the olfactory bulb. Additionally, increased NF-κB nuclear translocation and NLRP3 inflammasome components expressions caused by rotenone injection were observed accompanied by the activation of microglia and astrocytes in the olfactory bulb. Rotenone also triggered Drp1-mediated mitochondrial fission and this in turn caused mitochondrial damage. Furthermore, Mdivi-1(a selective Drp1 inhibitor) markedly ameliorated the morphologic disruptions of mitochondria and Drp1 translocation, inhibited the nuclear translocation of NF-κB, eventually blocked the downstream pathway of the NLRP3/caspase-1/IL-1ß axis and expression of iNOS. Overall, these findings suggest that Drp1-dependent mitochondrial fission induces NF-κB nuclear translocation and NLRP3 inflammasome activation that may further contribute to olfactory bulb disturbances.


Subject(s)
Dynamins/genetics , Olfactory Bulb/pathology , Parkinson Disease, Secondary/genetics , Parkinson Disease, Secondary/pathology , Rotenone/toxicity , Uncoupling Agents/toxicity , Animals , Dynamins/drug effects , Inflammasomes/genetics , Male , Mitochondria/drug effects , Mitochondria/pathology , Movement Disorders/pathology , Movement Disorders/psychology , NF-kappa B/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Neurons/pathology , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/genetics , Parkinson Disease, Secondary/chemically induced , Rats , Rats, Sprague-Dawley , Smell/genetics , Tyrosine 3-Monooxygenase/metabolism
10.
Clin Exp Pharmacol Physiol ; 47(5): 771-779, 2020 05.
Article in English | MEDLINE | ID: mdl-31925815

ABSTRACT

Gallic acid (GA) has a protective effect on the cardiovascular system. To study its cardiac electrophysiological effects, voltage-gated Na+ channel currents (INa ) were recorded in rat cardiomyocytes using whole-cell patch clamp techniques. Moreover, the effects of GA on aconitine-induced arrhythmias were assessed using electrocardiograms in vivo. We found that the current-voltage characteristic curve (I-V curve) of INa significantly shifted in the presence of 1, 3, and 10 µmol/L of GA. The peak sodium current density (INa -Peak) was reduced from -84.02 ± 5.68 pA/pF to -65.78 ± 3.96 pA/pF with 1 µmol/L, -54.45 ± 5.18 pA/pF with 3 µmol/L, and -44.20 ± 4.35 pA/pF with 10 µmol/L, respectively. GA shifted the steady-state activation curve of INa and recovery curve to the right and the steady-state inactivation curve to the left. The observed inhibitory effect was comparable to that of amiodarone. GA pre-treatment significantly prolonged the onset of fatal ventricular fibrillation. Our results indicated that GA inhibited INa in rat ventricular myocytes and aconitine-induced arrhythmias in vivo. These results suggest the potential of GA for development as a novel anti-arrhythmic therapeutic.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Gallic Acid/pharmacology , Heart Rate/drug effects , Myocytes, Cardiac/drug effects , Ventricular Fibrillation/prevention & control , Voltage-Gated Sodium Channel Blockers/pharmacology , Voltage-Gated Sodium Channels/drug effects , Aconitine , Action Potentials/drug effects , Animals , Disease Models, Animal , Electrocardiography , Female , Male , Myocytes, Cardiac/metabolism , Rats, Sprague-Dawley , Time Factors , Ventricular Fibrillation/chemically induced , Ventricular Fibrillation/metabolism , Ventricular Fibrillation/physiopathology , Voltage-Gated Sodium Channels/metabolism
11.
Oncol Lett ; 18(6): 6614-6620, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31788118

ABSTRACT

The recurrence and metastasis of hepatocellular carcinoma (HCC) are a major concern in current research. Epithelial-mesenchymal transition (EMT) is the leading cause underlying the high mobility and invasiveness of tumor cells. Myricetin is a natural flavonol with various pharmacological activities. The effects of myricetin on the migration and invasion of HCC MHCC97H cells were evaluated in the present study. Wound healing, Transwell migration and invasion assays were used to examine cell migration and invasion. Western blot analysis and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to examine the expression of epithelial (E)-cadherin, neural (N)-cadherin and vimentin. The present study aimed to investigate the effects of myricetin on the migration and invasion of HCC MHCC97H cells. It was indicated that myricetin decreased the viability of MHCC97H cells in a concentration and time-dependent manner, and inhibited MHCC97H cells migration and invasion. As the concentration of myricetin increased, filopodia and lamellipodia in cells weakened and cells were arranged more closely. RT-qPCR and western blotting revealed that myricetin upregulated E-cadherin expression and downregulated N-cadherin. Collectively, the results of the present study demonstrate that myricetin may inhibit the migration and invasion of HCC MHCC97H cells by inhibiting the EMT process.

12.
Zhongguo Zhong Yao Za Zhi ; 42(24): 4864-4869, 2017 Dec.
Article in Chinese | MEDLINE | ID: mdl-29493159

ABSTRACT

To investigate the effects of isovitexin Ⅳ on transient outward potassium current in rat ventricular myocytes. In this study, MTT assay was used to investigate the safe range of isovitexin. The results showed that the IC50 of the drug was in the range of 10-30 µmol•L⁻¹, and the drug concentration of 1-3 µmol•L⁻¹ for the patch clamp test was within the safe range. In addition, the single ventricular myocytes were obtained by single-enzymatic hydrolysis through aortic retrograde perfusion. The transient outward potassium current (Ito) of rat ventricular myocytes was guided and measured by whole-cell patch-clamp technique and the changes of current characteristics were recorded after isovite was applied. When the concentration of IV was less than 0.1 µmol•L⁻¹, there was no significant effect on Ito. However, with the increase in the concentration of IV (≥0.3 µmol•L⁻¹), the peak of Ito was decreased gradually, from (32.32±2.9) pA/pF to (25.83±4.3) pA/pF, 1 µmol•L⁻¹ IV and (19.51±3.5) pA/pF, 3 µmol•L⁻¹ IV respectively, with an inhibition effect in a concentration-dependent manner. In the range of 1-3 µmol•L⁻¹, IV down-regulated the I-V curve of Ito significantly. The activation curve showed that IV can enable the maximum half activation potential (V1/2) to move to the positive direction, and the V1/2 was increased from (19.59±1.6) mV to (22.81±1.7) mV and (28.86±1.4) mV at concentration of 1, 3 µmol•L⁻¹, meanwhile the activation curve moved to the right. However, the maximum half inactivating potential (V1/2) of the steady-state inactivation curve of Ito was significantly decreased from (-51.43±0.99) mV to (-61.81±1.3) mV with concentration of 1 µmol•L⁻¹ and (-71.50±1.4) mV with concentration of 3 µmol•L⁻¹. The inactivation time constant of recovery from inactivation (τ) was up-regulated significantly from (94.89±0.73) ms to (118.5±1.5) ms and (162.4±1.4) ms at concentration of 1, 3 µmol•L⁻¹ respectively. Meanwhile IV could enable the inactivation recovery curve to move to the right, which suggested that it can prolong the recovery time from inactivation of the transient outward potassium channel. In conclusion, isovitexin had a high inhibitory effect on Ito in rat ventricular myocytes.


Subject(s)
Apigenin/pharmacology , Myocytes, Cardiac/drug effects , Potassium Channels/metabolism , Transient Receptor Potential Channels/metabolism , Animals , Heart Ventricles/cytology , Patch-Clamp Techniques , Rats
13.
Oncol Rep ; 37(1): 259-272, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27840969

ABSTRACT

Human immediate early response 2 (IER2) has been reported to function as a potential transcriptional factor or transcriptional co­activator and seems to play a pivotal role in tumor cell motility and metastasis, however, its role and underlying mechanisms in hepatocellular carcinoma (HCC) remain unknown. Herein, we demonstrated that overexpression of IER2 in HCC cells increased cell adhesion to fibronectin, migration and invasion, whereas knockdown of IER2 displayed the opposite effects. In agreement with this phenotype, IER2 expression was positively correlated with the metastatic potential and integrin ß1 (ITGB1) expression in HCC cell lines. Moreover, we demonstrated a critical role for IER2 in regulation of HCC cell­extracellular matrix (ECM) adhesion and motility by the transcriptionally promoted ITGB1. Furthermore, we showed that ITGB1­focal adhesion kinase (FAK)­Src­paxillin signal pathway activated by IER2 may contribute to the HCC cell­ECM adhesion and motility. These results demonstrated that IER2 promoted HCC cell adhesion and motility probably by directly increasing ITGB1 expression and subsequently activating the ITGB1­FAK­Src­paxillin signal pathway.


Subject(s)
Carcinoma, Hepatocellular/pathology , Immediate-Early Proteins/metabolism , Integrin beta1/metabolism , Liver Neoplasms/pathology , Trans-Activators/metabolism , Carcinoma, Hepatocellular/metabolism , Cell Adhesion/genetics , Cell Line, Tumor , Cell Movement/genetics , Extracellular Matrix/metabolism , Fibronectins/metabolism , Focal Adhesion Kinase 1/genetics , Focal Adhesion Kinase 1/metabolism , Gene Knockdown Techniques , Humans , Immediate-Early Proteins/genetics , Liver Neoplasms/metabolism , Paxillin/genetics , Paxillin/metabolism , Signal Transduction , Trans-Activators/genetics
14.
J Cardiovasc Pharmacol ; 65(2): 153-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25295466

ABSTRACT

Adeno-associated virus (AAV) is a nonpathogenic virus capable of targeting human chromosome 19 for integration at AAVS1 site, and a 16 bp Rep binding element (RBE) sequence of AAV was sufficient for mediating this specific integration in the presence of AAV regulation proteins (Rep). Previously, we cotransduced 2 plasmids, pRBE-CMV-hFIX and pRC, into the AAVS1 transgenic mice by hydrodynamic injection, and a long-term expression of human coagulation Factor IX (hFIX) was observed. The corresponding AAVS1 locus site-specific integrations were verified by nested polymerase chain reaction. In this study, we established a novel hFIX expression plasmid, pRBE-HCR-hAAT-hFIX, driven by a liver-specific promoter by replacing the CMV promoter of pRBE-CMV-hFIX with a humanized promoter consisting of HCR-hAAT. The expression of hFIX in vitro was almost the same in transient transfection of pRBE-CMV-hFIX or pRBE-HCR-hAAT-hFIX. AAVS1-specific integrations were identified both in mice transfected with pRC/pRBE-CMV-hFIX cocktail and pRC/pRBE-HCR-hAAT-hFIX cocktail. However, the expression of hFIX of pRBE-HCR-hAAT-hFIX mice was higher and persisted longer. It achieved more than 1% of normal plasma hFIX concentration and maintained for 240 days. The result suggested that RBE-HCR-hAAT element could improve the expression of hFIX and present potential usage of Rep-RBE site-specific integration in gene therapy for hemophilia B.


Subject(s)
Chromosomes, Human, Pair 19 , DNA-Binding Proteins/genetics , Genetic Therapy/methods , Hemophilia B/therapy , Viral Proteins/genetics , Animals , Cells, Cultured , Dependovirus/physiology , Factor IX/genetics , Gene Transfer Techniques , Genetic Vectors , Humans , Liver/metabolism , Mice , Mice, Transgenic , Plasmids/physiology , Promoter Regions, Genetic
15.
Can J Microbiol ; 60(5): 255-66, 2014 May.
Article in English | MEDLINE | ID: mdl-24766220

ABSTRACT

There is an increasing movement against use of antibiotic growth promoters in animal feed. Prebiotic supplementation is a potential alternative to enhance the host's natural defense through modulation of gut microbiota. In the present study, the effect of mannan oligosaccharide (MOS) and virginiamycin (VIRG) on cecal microbial ecology and intestinal morphology of broiler chickens raised under suboptimal conditions was evaluated. MOS and VIRG induced different bacterial community structures, as revealed by denaturing gradient gel electrophoresis of 16S rDNA. The antibiotic treatment reduced cecal microbial diversity while the community equitability increased. A higher bacterial diversity was observed in the cecum of MOS-supplemented birds. Quantitative polymerase chain reaction results indicated that MOS changed the cecal microbiota in favor of the Firmicutes population but not the Bacteroidetes population. No difference was observed in total bacterial counts among treatments. MOS promoted the growth of Lactobacillus spp. and Bifidobacterium spp. in the cecum and increased villus height and goblet cell numbers in the ileum and jejunum. These results provide a deeper insight into the microbial ecological changes after supplementation of MOS prebiotic in poultry diets.


Subject(s)
Cecum/microbiology , Chickens/growth & development , Chickens/microbiology , Mannans/administration & dosage , Prebiotics , Animals , Anti-Bacterial Agents/administration & dosage , Cecum/cytology , Cecum/drug effects , Denaturing Gradient Gel Electrophoresis , Dietary Supplements/analysis , Intestines/cytology , Intestines/drug effects , Intestines/microbiology , Lactobacillus , Male , Virginiamycin/administration & dosage
16.
Zhong Xi Yi Jie He Xue Bao ; 2(3): 210-2, 2004 May.
Article in Chinese | MEDLINE | ID: mdl-15339448

ABSTRACT

OBJECTIVE: To investigate the effect of Compound Rhubarb Mixture on contraction of isolated small intestinal smooth muscle of rabbit. METHODS: Serum containing Compound Rhubarb Mixture was prepared. The contraction curves of isolated small intestinal smooth muscle before and after administration of the serum were recorded by Medlab biological information collecting system. RESULTS: The serum containing Compound Rhubarb Mixture amplified the contraction amplitude of isolated small intestinal smooth muscle of rabbit. The rate of change of contraction amplitude was elevated significantly after administration, while the frequency of contraction did not change obviously. CONCLUSION: The serum containing Compound Rhubarb Mixture can enhance the contractive function of isolated small intestinal smooth muscle of rabbit.


Subject(s)
Intestine, Small/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Plant Preparations/pharmacology , Rheum , Animals , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/pharmacology , Female , In Vitro Techniques , Male , Muscle, Smooth/physiology , Rabbits
17.
Acta Pharmacol Sin ; 23(2): 110-6, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11866869

ABSTRACT

AIM: To study the properties of transient outward K+ current (Ito) and ultra-rapid delayed rectifier K+ current (IKur) in isolated human atrial myocytes from patients with congestive heart failure (CHF). METHODS: Single cells were isolated from CHF patients with collagenase and protease. Ito and IKur were recorded using whole cell patch-clamp technique. RESULTS: The activation and inactivation of I(to) were voltage-dependent and time-dependent. The half-activation and half-inactivation voltage were (15 +/- 12) mV and (-45 +/- 4) mV respectively. When membrane potential went up from -40 mV to +60 mV, the activation time constant means decreased from (6.9 +/- 2.3) ms to (1.40 +/- 0.20) ms, while the inactivation time constant means decreased from (69 +/- 17) ms to (21 +/- 14) ms. Otherwise, the mean reactivation time constants was (125 +/- 65) ms when the membrane potential was held at -80 mV, but the recovery was not complete during the interval observed. Ito showed less frequency-dependent reduction at test frequency between 0.2-2 Hz. Compared with Ito, the activation of IKur only showed voltage-dependence, without time-dependence. Its mean current densities was (3.4 +/- 0.7) pA/pF when test potential was +60 mV. The half activation voltage of IKur was (23 +/- 14) mV. No clear frequency-dependence was observed at the same frequency range of Ito either. CONCLUSION: I(to) and IKur are important outward potassium channel currents in isolated human atrial myocytes from CHF patients and they have different kinetic properties.


Subject(s)
Heart Failure/pathology , Muscle Cells/metabolism , Potassium Channels, Voltage-Gated , Potassium Channels/physiology , Adolescent , Adult , Cell Separation , Delayed Rectifier Potassium Channels , Heart Atria/pathology , Heart Failure/metabolism , Humans , Membrane Potentials/physiology , Middle Aged , Muscle Cells/physiology , Patch-Clamp Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...